HJ
Heidy King-Jones (See Remarks) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Spyre Therapeutics, Inc. (SYRE). The largest single filing was $2.6M of SYRE (28,533 sh across 4 lots, as filed), executed Oct 1. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.0M
shares × price, as filed
Last traded
Oct 1
Filed Oct 2
Median ADV $134.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
SYRERecent filings
SYRESALE
Spyre Therapeutics, Inc.
View filing →
$2.6M28,533 sh across 4 lots
Exec Oct 1
Filed Oct 2 · 9:30 PM ET SYRESALE Spyre Therapeutics, Inc. View filing → $2.4M
27,599 sh across 3 lots
Exec Sep 1
Filed Sep 3 · 9:34 PM ET